A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Clinical trial NCT05746897 · RECRUITING

Trial details

NCT number: NCT05746897
Sponsor: Hefei TG ImmunoPharma Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Melanoma Triple Negative Breast Cancer Colorectal Cancer

Start date: 2023-04-13
Primary completion: 2027-09-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.